NARD

Menu

JAPAN

Company
profile and history

Company profile

Trading name NARD Institute, Ltd.
Locations Headquarters:
2-6-1 Nishinagasu-cho, Amagasaki City, Hyogo Prefecture 660-0805, Japan
TEL.+81-6-6482-7010  FAX.+81-6-6482-8020
Kobe Research Laboratory:
5-4-1 Minatojima Minamimachi, Chuo-ku, Kobe City, Hyogo Prefecture 650-004, Japan
+81-78-958-7011  FAX.+81-78-958-8021
Executives Yukio Dohi, President and CEO
Akihiko Kawasaki, Chief Operating Officer
Isao Hirota, Director
Yuzo Ogawa, Director
Mitsuhiro Asakura, Executive Officer
Hirohisa Otsuka, Auditor
Masaichi Nomura, Auditor (licensed certified public accountant)
Senior Advisor Teruhiro Arakawa
Establishment March 14, 1972
Capital investment 100,000,000 JPY
Employees 133 (as of end of December, 2019)
Technical Advisers Hiroshi Akimoto, PhD (pharmacology). Formerly, executive managing director, Takeda Pharmaceutical Co., Ltd.
Katsuhiro Ono, PhD (science). Formerly, executive managing director, Idemitsu Kosan, Ltd.
Group company About NARD Chemicals

Corporate History

1972
Mar.
Originally located at Minamimorimachi, Kita-ku, Osaka City,
with an investment capital of 5,000,000 JPY
Morimasa Arakawa becomes the company president
Dec.
The Research Laboratory was established in Chifune, Nishiyodogawa-ku, Osaka City
1975
May
Headquarters relocated to Chifune, Nishiyodogawa-ku, Osaka City
1987
May
Morimasa Arakawa becomes the chairman
Koichi Hirooka becomes the company president
1989
Nov.
Relocation to the present location
Investment capital (20,000,000 JPY) received
from Osaka Small and Medium Business Investment & Consultation Co., Ltd.
Investment capital increased to 50,000,000 JPY
1995
Mar.
Investment capital increased to 55,000,000 JPY
1997
Mar.
Norio Minami becomes company president
Investment capital increased to 63,250,000 JPY
1998
Mar.
Investment capital increased to 75,900,000 JPY
1999
Mar.
Investment capital increased to 91,080,000 JPY
2000
June
Annex to main office building constructed
2007
Mar.
Ken Kitashoji becomes company president
Investment capital increased to 100,180,000 JPY
Oct.
Kobe Laboratory established
2012
Dec.
Kobe Laboratory relocated to Kobe Port Island
2014
Mar.
Yukio Doi appointed president
2018
Sep.
Investment capital decreased to 100,000,000

Patent applications as of the end of December 2019: 196 (Refer to J-PlatPat for details)
Revenue: 3,600,000,000 JPY (FY 2019)

Contact Nard Institute

Please contact us for consultations or inquiries.

Contact Us

Recommended contents

Contract synthesis
Highly Active Pharmacological Substances
Contract Manufacturing
Thio-tag Technology
Custom Synthesis of Phos-tag Derivatives
Hydroxy group protecting agent - TriBOT
Organic synthesis support through experimentation and theoretics